Luminescent properties of a terbium (Tb 3+ )-L-3, 4-dihydroxyphenylalanine (L-dopa) complex by binding to colloidal silver nanoparticles (Ag NPs) have been presented. Luminescence intensity of the L-dopa complex was dramatically enhanced about 6-7 times by introducing Ag NPs. The Ag NPs concentration on the luminescent intensity was regarded as a main factor that balancing between an enhancing and a quenching effect of the Ag NPs. It was observed that changing the concentration of L-dopa causes the change in luminescence intensity. Under the optimized condition, the luminescence intensity of the system was linearly related to the concentration of L-dopa. Based on this observation, L-dopa-Tb 3+ complex containing Ag NPs has been applied for the determination of L-dopa in pharmaceutical formulation. Linear responses of luminescence intensity were observed in the concentration range of 0.25 to 1.5 nM (r = 0 9934) of L-dopa with limit of detection 0.042 nM. The performance of the system was tested using 1 0 × 10 −9 M of L-dopa, yielding a precision of 1.21% RSD for nine replicate measurements. The present method has been successfully applied to determine L-dopa in pharmaceutical samples.
INTRODUCTION
Lanthanide ions such as terbium and europium ions and their complexes are interested in various nanotechnology and biotechnology applications such as fluorescence materials, electroluminescence devices, fluorescence labels and probes. [1] [2] [3] [4] Lanthanides in an aqueous solution are known to be either non-fluorescent or weakly fluorescent due to their low molar absorptivities and poor quantum yields. 5 However, luminescence property of lanthanide ions, in particular terbium (Tb 3+ ) and europium (Eu 3+ ) ions, can be dramatically enhanced by forming a chelate with ligands that have a broad intense absorption band. In this process, an efficient intramolecular energy transfer occurs from the excited triplet state of the ligands to the emitting level of the lanthanide ion. [6] [7] [8] This sensitization process is not diffusion controlled because the lanthanide ion combines with ligands as donors by coordinate linkage. These ions form stable luminescent complexes with bidentate or multidentate ligands, especially when negatively charged oxygen donating groups are involved in ligand structures. 9 It is * Authors to whom correspondence should be addressed.
well reported that lanthanide sensitized luminescence provide large Stokes shift, narrow emission bands and long luminescence lifetimes. 10 In recent years, it has been well established that metallic nanostructures can modify the spectral properties of fluorophores. [11] [12] [13] Metal-fluorophores interactions that greatly enhance the luminescence intensity are termed as metal-enhanced fluorescence (MEF). 12 It is concluded in the study of MEF that fluorescent species are excited with an external light source and the energy from the electronically excited states is partially transferred or coupled to surface plasmons in metallic nanostructure. 14 The coupled emission may be consequently emitted by the metalfluorophore "unified system" with the identical spectral characteristics of the selected fluorophore. 15 Recently many applications of MEF have been demonstrated including various bioassays. [16] [17] Solution-based MEF has also been presented by the Institute of Fluorescence, University of Maryland Biotechnology Institute. [18] [19] In this work, the luminescence of Tb 3+ and Tb 3+ -L-3, 4-dihydroxyphenylalanine (L-dopa) complex by binding to silver nanoparticles (Ag NPs) in solution has been presented. L-dopa is an important neurotransmitter and is used for the treatment of neural disorders such as Parkinson's disease. 20 L-dopa is capable to form a strong chelate with Tb 3+ ions because it contains an active group in the form of -COOH and -OH in the structure. It is already reported that terbium and europium ion can bind to form complex with similar organic ligand such as norfloxacin, nalidixic acid, ciprofloxacin, gatifloxacine. [21] [22] [23] It was observed that weak luminescence of Tb 3+ was enhanced strongly when it is chelated with L-dopa. The addition of the colloidal solution of Ag NPs to the Tb 3+ -L-dopa complex enhanced the luminescence intensity spectacularly by 6-7 times. The enhancement of luminescence signal from L-dopa-Tb 3+ -Ag NPs system was responded linearly with the concentration of L-dopa under optimized condition. Therefore, the Ag NPs modified luminescence of Tb 3+ complex has been applied for the determination of L-dopa in a biological sample. To the best of our knowledge there is no report for the determination of L-dopa using the proposed method. As we were to utilize this enhancement process for analysis of L-dopa concentrations, the influences of involved reagents and other reaction conditions were to be systematically studied and optimized. Important analytical parameters such as linear range, detection limits, and repeatability should be assessed under the finally optimized conditions. If such parameters turned out to be satisfactory, the feasibility of applications to real samples such as pharmaceutical formulation was to be tested.
EXPERIMENTAL DETAILS

Reagents and Solution
L-dopa, terbium chloride (TbCl 3 • 6H 2 O), tris (hydroxymethyl) amino methane, silver nitrate and sodium borohydride were obtained from Sigma-Aldrich. Other reagents used for this study were of analytical grade purity from a standard supplier. The primary stock solutions of the L-dopa (1 0 × 10 −2 M) were prepared using 0.1 M hydrochloric acid and deionized (DI) water. Stock solution of terbium chloride (1 0 × 10 −2 M) was prepared using DI water. The prepared stock solutions were stored in refrigerator at 4 C. Tris-HCl buffer was prepared by dissolving appropriate amount of tris (hydroxymethyl) amino methane in 500 mL DI water and pH was adjusted using 0.1 M HCl. 1.0 mM of silver nitrate and 2.0 mM of sodium borohydride solution were prepared by dissolving in DI water. Working solutions were prepared daily before use by required dilution of the stock solution.
Preparation and Characterization of Ag NPs
Ag NPs were prepared in accordance with the procedure described in a literature with some modification. 24 Briefly, 30 mL of 2 mM NaBH 4 aqueous solution was taken in an Erlenmeyer flask and chilled in an ice bath under vigorous stirring then 10 mL of 1 mM AgNO 3 aqueous solution was added drop wise until the color of the colloidal solution was turned into light yellow. The color changing of the solution indicates the complete reduction of silver ions. This colloidal solution was stored at 4 C before using. The prepared Ag NPs were characterized by UV-visible spectrum using a UV-visible spectrophotometer (UV-1800, Shimadzu, Japan) and transmission electron microscopic (TEM) images using a Transmission electron microscope (TEM, Hitachi-7100, Japan) with an accelerating voltage of 100 kV. The TEM image of Ag NPs showed that the average diameters of the particles are approximately 15 ± 2 nm according to the scaling as depicted in Figure 1 . The prepared Ag NPs exhibited intense absorption maximum at about 400 nm as shown in Figure 2 (e) which is the characteristic plasmonic band of Ag NPs. 25 
Apparatus and Procedure
Luminescence measurements were conducted using a spectrofluorometer (F-4500, Hitachi, Japan) equipped with a 150 W xenon lamp and photomultiplier tube (Model R 928, Hamamatsu, Japan). A pH meter (Orion, 520A, USA) was used for pH adjustment. UV-visible spectra were recorded by the UV-visible spectrophotometer. All experiments were performed at room temperature.
The following procedure was adopted for luminescence measurements. A certain volume of terbium chloride, 1.0 mL of buffer (pH, 8.5), appropriate volume of L-dopa solution were added to a 10 mL-volumetric flask. The mixture was diluted with 5 mL double DI water and allowed to stand for several minute to form complex and then a certain volume of colloidal solution of Ag NPs was added to the complex. The luminescence spectra of Tb 3+ , L-dopaTb 3+ complex and L-dopa-Tb 3+ -Ag NPs were measured in 
-Ag NPs, and (e) Ag NPs.
a 1 cm quartz cell with the excitation and emission wavelengths of 279 nm and 490 nm, respectively. The both excitation and emission slits for luminescence measurements were 10 nm. The high voltage for the photomultiplier tube was set to 950 V.
RESULTS AND DISCUSSION
Absorption and Luminescence Spectra
UV-visible spectra of Tb 3+ , L-dopa, L-dopa-Tb 3+ and L-dopa-Tb 3+ -Ag NPs were recorded separately in order to comprehend the formation of complex and interaction of the complexes with Ag NPs. Figure 2(a) shows the characteristic UV spectra of Tb 3+ with absorbance maximum at around 218 nm and L-dopa (Fig. 2(b) ) with absorbance maxima at around 221 nm and 279 nm. As shown in Figure 2 (c), the absorption maxima of the L-dopa found to be red shifted from 221 to 242 nm and 279 to 294 nm after reaction with Tb 3+ solution in presence of tris-HCl buffer. This wavelength shifting indicates the formations of L-dopa-Tb 3+ complex. The UV-visible absorption spectra of the L-dopa-Tb 3+ complex containing colloidal solution of Ag NPs display further shifting of absorbance maxima of the L-dopa with a new absorbance maximum at around 400 nm (Fig. 2(d) ). This observation clearly indicates the interaction of Ag NPs with the L-dopa-Tb 3+ complex. Tb 3+ in aqueous medium emits very weak luminescence ( Fig. 3(a) ) due to weak absorption of metal ion itself. It can act as an energy acceptor from the lowest triplet state of organic ligand having strong absorption in the UV region. 26 Therefore, enhanced luminescence of Tb 3+ is occurred from the ligand-Tb 3+ interaction. When the L-dopa-Tb 3+ complex in solution was excited at 279 nm near the absorption wavelength of L-dopa, the enhanced emission band was observed at 490 nm and 545 nm (Fig. 3(b) ) which are the characteristic luminescence peaks of Tb 3+ corresponding to the transitions of may cause the enhancement of native weak luminescence of Tb 3+ originating from the intra-chelate energy transfer from the triplet state of the organic ligand (L-dopa) to the excited energy levels of Tb 3+ ion. 27 The addition of the colloidal solution of Ag NPs to the L-dopa-Tb 3+ complex enhanced the luminescence intensity spectacularly by 6-7 times (Fig. 3(c) ) compared to that of the L-dopa-Tb 3+ complex ( Fig. 3(b) ).
The interaction of Ag NPs with fluorophores has been reported to alter the free space absorption condition, which dramatically change the spectra from those observable in the absence of metallic nano surfaces. 16 The spherical particles can enhance the extent of resonance energy transfer to the fluorophores through the interaction of the excitedstate fluorophores and surface plasmon electron in the metal NPs. 28 In this concept, the L-dopa-Tb 3+ complex may interact with the surface plasmon electrons of Ag NPs. Fluorophores (Tb 3+ ) may be in close proximity with the Ag NPs in that state. In this condition, when Ag NPs containing the L-dopa-Tb 3+ complex solution are excited, two processes may arise: (1) non-radiative coupling from the excited fluorophores (Tb 3+ ) to the surface plasmonic electrons of Ag NPs, which are subsequently radiated by the NPs themselves, and (2) enhancement of the absorption of light by the fluorophores due to increased electric field between and around the NPs. shows (Fig. 3(c) ) that the intensity of the excitation spectra was strongly enhanced by 5-6 times than that of the L-dopa-Tb 3+ complex (Fig. 3(b) ). This suggested that the Ag NPs enhanced the luminescence of the L-dopa-Tb 3+ complex in the solution phase due to the increased local excitation fields around the edges of the particles.
Optimization of Reaction Parameters
The influence of pH of the L-dopa-Tb 3+ -Ag NPs system on the luminescence intensity was investigated. The results showed that the luminescence intensity is increasing with the pH value from 7.0 to 8.5 and decreasing slowly above 8.5. Therefore pH 8.5 was selected as the optimum pH value for this experiment.
Concentrations of a colloidal solution of Ag NPs influenced the luminescence intensity of the system. The concentration effect was examined by varying the concentration of the colloidal solution from 2 2 × 10 and europium. [30] [31] The dependence of the system's luminescence intensity on the concentration of the colloidal solution indicates a dependence on the Ag NP concentration, which suggests that metal NPs can enhance or quench the luminescence. [32] [33] When the colloidal solution of Ag NPs was added to the Tb 3+ -L-dopa complex, the local refractive index around the terbium complex might have been changed and the electric dipole transition rate thereby modified. A colloidal solution concentration of more than 1 15 × 10 −4 M may distort the local field arising from the self-interaction of plasmon electrons of Ag NPs. 34 This effect might have quenched the luminescence intensity. The maximized enhancement efficiency for the 1 15× 10 −4 M colloidal solution may thus be attributed to a delicate balance between the enhancement and quenching effect.
The influence of Tb 3+ concentration on the luminescence intensity of the system was investigated varying the concentration in the range of 2 0 × 10 −5 − 5 × 10 −4 M. Figure 5 shows that luminescence intensity reached a plateau with a Tb 3+ concentration of 2 2 × 10 −4 M. The stable and good reproducibility of luminescence intensity of the system was obtained using 2 75 × 10 −4 M Tb 3+ . Therefore, 3 5×10 −4 M Tb 3+ was used in following experiments as the optimum concentration.
Analytical Characteristics
Under the aforementioned optimal conditions, luminescence intensity of the L-dopa-Tb 
Interferences
The effects of some potentially interfering ions that can coexist in pharmaceutical samples were investigated. They can suppress or enhance the luminescence signal. Effect of the potential interferents was therefore investigated by . Thus, the effects of these possible interferents could be ignored. And this technique can be applied for determination of L-dopa.
Application to Real Samples
The present method was applied for the determination of L-dopa in pharmaceutical formulation collected from the local pharmacy. Five tablets of containing L-dopa were properly weighed and pulverized into homogenized powder. An accurately weighed amount of 100 mg of tablet powder was transferred into a beaker. The powder was dissolved in methanol. The solution was filtered through a filter millex (0.22 m pore size, Millipore) to isolate the insoluble excipients and was washed with water five times. Finally the solution was diluted appropriately to meet the linear range. The obtained results are summarized in Table I . There were no significant differences between the labeled content and that obtained by the present method. Recovery studies were also performed on the analyzed samples by standard addition method. Recoveries were found in the range of 98-101.3%. Therefore the investigated system can be applied for the determination of L-dopa in pharmaceutical sector.
CONCLUSIONS
The luminescence of L-dopa-Tb 3+ complex in solution was highly enhanced by adding Ag NPs. Under the optimized condition, the luminescence intensity was enhanced linearly with the concentration of L-dopa. Therefore the Ag NPs enhanced luminescence of terbium-L-dopa complex has been applied for the determination of L-dopa in pharmaceutical formulation with satisfactory results.
